AstraZeneca Financial Statements
AstraZeneca Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
AstraZeneca Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 29,559.0 | -- | 23,950.0 |
| Gross Profit ($ mil.) | 22,892.0 | -- | 18,594.0 |
| Operating Income ($ mil.) | 8,094.0 | -- | 5,355.0 |
| Total Net Income ($ mil.) | 5,627.0 | -- | 3,884.0 |
| Diluted EPS (Net Income) | -- | -- | 2.40 |
AstraZeneca Stock Quote & Chart
07/03/08 12:00:22 EST •
NYSE •
45.80
•
 +1.6700
•
+3.7843 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
AstraZeneca Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.20 | 3.77 | 1.54 |
| Price/Earnings Ratio | -- | 15.99 | 15.14 |
| Price/Book Ratio | 0.40 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | 0.78 | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed AstraZeneca Financial Ratios
AstraZeneca Competitive Intelligence
| GlaxoSmithKline | Merck | Novartis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 45,816.1 | 24,197.7 | 38,947.0 |
| Employees | -- | 59,800 | 98,200 |
| Market Cap ($ mil.) | -- | 80,902.6 | -- |
Competitive Landscape
